9 Meters Biopharma

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, 9 Meters Biopharma sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 7 completed early-phase tilt top decile by trial count

9 Meters Biopharma: 9 sponsored US clinical trials, none currently recruiting.

9 Meters Biopharma sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage).

Top-decile sponsor footprint

9 Meters Biopharma ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

9 total, page 1 of 1

TERMINATED Phase 2

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

NCT04988997
TERMINATED Phase 3

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

NCT03569007
COMPLETED Phase 2

A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

NCT01396213
COMPLETED Phase 2

Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease

NCT00889473
COMPLETED Phase 2

Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

NCT00620451
COMPLETED Phase 2

Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

NCT00492960
COMPLETED Phase 2

Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

NCT00362856
COMPLETED Phase 1

Safety of Larazotide Acetate in Healthy Volunteers

NCT00386490
COMPLETED Phase 1

Safety Study of Larazotide Acetate to Treat Celiac Disease.

NCT00386165

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 6
Phase 3 1

How the 9 Meters Biopharma early-phase archive is shaped

9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).

Phase mix: 1 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Therapeutic area indexing for this sponsor is limited in the public registry.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

9 Meters Biopharma: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

9 Meters Biopharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share 9 Meters Biopharma4D Molecular TherapeuticsAadi BioscienceAblynx, a Sanofi companyAcacia Pharma10xBio22nd Century Group23andMe3-C Institute for Social Development
9 Meters Biopharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

9 Meters Biopharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this 9 Meters Biopharma page

9 registered trials is a research-attention snapshot, not an endorsement of 9 Meters Biopharma or any single study.

  • None of 9 Meters Biopharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

9 Meters Biopharma pipeline card: 9 registered trials from official public datasets.Report a data error.